Home > Quotes > BAX

Baxter International Inc. Stock Quote & Summary Data

BAX 
$70.88
*  
0.15
  negative  
0.21%
Get BAX Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target: 77
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 3,314,189
Previous Close: $ 70.73
52 Week High /Low: $ 73.95 / $ 49.15
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 38,413,560,595
P/E Ratio: 17.12
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 15.18
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 4.14
Annualized dividend $ 1.96
Ex Dividend Date Jun. 5, 2013
Dividend Payment Date Jul. 1, 2013
Current Yield 2.77 %
Beta 0.87

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

ETFs with BAX as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.72% SPDR S&P Health Care Equipment (XHE) +2.99  (5.53%)
2.15% Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH) +6.25  (8.47%)
1.32% First Trust Value Line Equity Allocation Index(sm)Fund (FVI) +2.73  (14.78%)
0% Schwab US Dividend Equity ETF (SCHD) +3.81  (12.81%)

We make it easy to follow the leaders. PowerShares QQQ. 100 companies at the top of innovation in one fund.


*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

**Green highlights the top performing ETF by % change in the past 100 days.

 Company Description (as filed with the SEC)

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision. Baxter manufactures products in 27 countries and sells them in more than 100 countries. Baxter International Inc. was incorporated under Delaware law in 1931.  ... More ...  



News Headlines for BAX

Where Is Biotechnology's Next 'Anti-PD-1'?
6/18/2013 7:57:00 AM - Seeking Alpha
UPDATE: Lilly Ends Alzheimer's Drug Study On Safety Concern
6/13/2013 6:05:00 PM - Dow Jones Business News
High- And Low-Quality Stocks Beat The S&P 500
6/12/2013 2:29:00 PM - Seeking Alpha
High- And Low-Quality Stocks Beat The S&P 500
6/12/2013 2:11:51 PM - SeekingAlpha
Bear of the Day: Covidien (COV) - Bear of the Day
6/12/2013 5:02:01 AM - Zacks.com
 

Consensus Recommendation